American Society for Clinical Pharmacology and Therapeutics position statement on the public health risks of ephedra.
Hollister
Alan S
AS
Division of Clinical Pharmacology and Medical Toxicology, Children's Mercy Hospitals and Clinics, Kansas City, MO 64108, USA.
Kearns
Gregory L
GL
D001067:Appetite Depressants / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000453:epidemiology; D004348:Drug Labeling; D029789:Ephedra / Q000009:adverse effects*; D004809:Ephedrine / Q000009:adverse effects*; D006801:Humans; D009422:Nervous System Diseases / Q000139:chemically induced / Q000453:epidemiology; D004366:Nonprescription Drugs; D010601:Pharmacology, Clinical; D012958:Societies, Scientific; D014481:United States / Q000453:epidemiology
D001067:Appetite Depressants; D004366:Nonprescription Drugs; D004809:Ephedrine